Literature DB >> 10369063

Continuing care for cocaine dependence: comprehensive 2-year outcomes.

J R McKay1, A I Alterman, J S Cacciola, C P O'Brien, J M Koppenhaver, D S Shepard.   

Abstract

This report presents 2-year outcome data from an outpatient continuing care study in which cocaine-dependent patients (N = 132) were randomly assigned to either standard group counseling (STND) or individualized relapse prevention (RP). Data on cocaine outcomes during the 6-month treatment phase of the study were presented in an earlier report (J. R. McKay, A. I. Alterman, J. S. Cacciola, M. R. Rutherford, & C. P. O'Brien, 1997). In the present report, a continuing care condition main effect was obtained on only 1 of 8 outcome variables examined. However, patients who endorsed a goal of absolute abstinence on entering continuing care had better cocaine use outcomes in RP than in STND, whereas the opposite was the case for those with less stringent abstinence goals. In addition, patients with current cocaine or alcohol dependence on entering continuing care who received RP had better cocaine use outcomes in Months 1-6 and better alcohol use outcomes in Months 13-24 than those in STND.

Entities:  

Mesh:

Year:  1999        PMID: 10369063     DOI: 10.1037//0022-006x.67.3.420

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  21 in total

1.  Treatment outcomes of a stage 1 cognitive-behavioral trial to reduce alcohol use among human immunodeficiency virus-infected out-patients in western Kenya.

Authors:  Rebecca K Papas; John E Sidle; Benson N Gakinya; Joyce B Baliddawa; Steve Martino; Michael M Mwaniki; Rogers Songole; Otieno E Omolo; Allan M Kamanda; David O Ayuku; Claris Ojwang; Willis D Owino-Ong'or; Magdalena Harrington; Kendall J Bryant; Kathleen M Carroll; Amy C Justice; Joseph W Hogan; Stephen A Maisto
Journal:  Addiction       Date:  2011-08-18       Impact factor: 6.526

2.  Mediators of effectiveness in dual-focus self-help groups.

Authors:  Stephen Magura; Edward L Knight; Howard S Vogel; Daneyal Mahmood; Alexandre B Laudet; Andrew Rosenblum
Journal:  Am J Drug Alcohol Abuse       Date:  2003-05       Impact factor: 3.829

Review 3.  Evidence-based practices for substance use disorders.

Authors:  Mark P McGovern; Kathleen M Carroll
Journal:  Psychiatr Clin North Am       Date:  2003-12

Review 4.  Recent advances in the psychotherapy of addictive disorders.

Authors:  Kathleen M Carroll
Journal:  Curr Psychiatry Rep       Date:  2005-10       Impact factor: 5.285

5.  Mediators of telephone-based continuing care for alcohol and cocaine dependence.

Authors:  Janell Lynn Mensinger; Kevin G Lynch; Thomas R TenHave; James R McKay
Journal:  J Consult Clin Psychol       Date:  2007-10

Review 6.  Personalized treatment of alcohol dependence.

Authors:  Henry R Kranzler; James R McKay
Journal:  Curr Psychiatry Rep       Date:  2012-10       Impact factor: 5.285

7.  Who benefits from extended continuing care for cocaine dependence?

Authors:  James R McKay; Deborah H A Van Horn; Kevin G Lynch; Megan Ivey; Mark S Cary; Michelle Drapkin; Donna Coviello
Journal:  Addict Behav       Date:  2013-12-01       Impact factor: 3.913

8.  An adaptive approach for identifying cocaine dependent patients who benefit from extended continuing care.

Authors:  James R McKay; Deborah H A Van Horn; Kevin G Lynch; Megan Ivey; Mark S Cary; Michelle L Drapkin; Donna M Coviello; Jennifer G Plebani
Journal:  J Consult Clin Psychol       Date:  2013-09-16

9.  Randomized trial of continuing care enhancements for cocaine-dependent patients following initial engagement.

Authors:  James R McKay; Kevin G Lynch; Donna Coviello; Rebecca Morrison; Mark S Cary; Lauren Skalina; Jennifer Plebani
Journal:  J Consult Clin Psychol       Date:  2010-02

10.  Extending residential care through telephone counseling: initial results from the Betty Ford Center Focused Continuing Care protocol.

Authors:  John S Cacciola; Amy C Camilleri; Deni Carise; Samuel H Rikoon; James R McKay; A Thomas McLellan; Cheryl Wilson; John T Schwarzlose
Journal:  Addict Behav       Date:  2008-05-14       Impact factor: 3.913

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.